Orexigen Therapeutics, Inc. (NASDAQ:OREX) Reported Basic Consolidated EPS Of $-5.2381

0

For the period ended 2015-12-31, Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported $-5.2381 as the annual basic consolidated EPS. On quarterly basis, $-5.2381 was captured as the basic consolidated EPS reading for the quarter ended 2015-12-31.

EPS from continuing operations

For the annual period ended 2015-12-31 and in line with the basic EPS from continuing operations Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported $-5.2381. For the three-month period ended 2015-12-31, quarterly basis EPS from continuing operations stood at $-5.2381.

EPS contribution from parent

Basic EPS received by Orexigen Therapeutics, Inc. (NASDAQ:OREX) from its parent company was $-5.2381 for the annual period ended 2015-12-31. For the period ended 2015-12-31, the quarterly basis the basic EPS contribution from the parent company was $-5.2381.

Basic net EPS

Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported basic net EPS of $-5.2 for the annual period ended 2015-12-31. The company’s basic net EPS on a quarterly basis stood at $-5.2 for the three-month period ended 2015-12-31.

Consolidated diluted EPS

The period ended 2015-12-31 had an annual consolidated diluted EPS reading of $-5.2381. Consolidated diluted EPS for the quarter ended 2015-12-31 was $-5.2381.

b>Basic diluted EPS

For the period ended 2015-12-31 diluted EPS reading from continuing operation on annual basis was $-5.2381. However, $-5.2381 was registered as the Diluted EPS from continuing operations for the quarter ended 2015-12-31.

Net diluted EPS

For the annual period ended 2015-12-31, $-5.2 was the Net diluted EPS reading. But the quarterly period that ended 2015-12-31, net diluted EPS was $-5.2.

Diluted EPS from parent

Orexigen Therapeutics, Inc. (NASDAQ:OREX) received diluted EPS of $-5.2381 from the parent company which was for the annual period ended 2015-12-31. However, on quarterly basis, $-5.2381 was the diluted EPS contribution from the parent for the quarter ended 2015-12-31. The net basic EPS reading of $-5.2 was posted by Orexigen Therapeutics, Inc. (NASDAQ:OREX) which was representing the annual period ended 2015-12-31. Basic net EPS of $-5.2 was for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Net diluted EPS was $-5.2 for the annual period ended 2015-12-31. There was also a report by the company of $-5.2 being the net diluted EPS reading for the quarter ended 2015-12-31.

While the shares for the quarter ended 2015-12-31 were at 14.566, the period ended 2015-12-31 is 14.566 being the annual average basic shares outstanding.

For the fiscal year ended is 2015-12-31 while 14.566 represents the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 24 times, 1 visits today)